Fluorescence lifetime of actin in the familial hypertrophic cardiomyopathy transgenic heart

P. Mettikolla, R. Luchowski, I. Gryczynski, Z. Gryczynski, D. Szczesna-Cordary, J. Borejdo

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Clinical studies have revealed that the D166V mutation in the ventricular myosin regulatory light chain (RLC) can cause a malignant phenotype of familial hypertrophic cardiomyopathy (FHC). It has been proposed that RLC induced FHC in the heart originates at the level of the myosin cross-bridge due to alterations in the rates of cross-bridge cycling. In this report, we examine whether the environment of an active cross-bridge in cardiac myofibrils from transgenic (Tg) mice is altered by the D166V mutation in RLC. The cross-bridge environment was monitored by tracking the fluorescence lifetime (τ) of Alexa488-phalloidin- labeled actin. The fluorescence lifetime is the average rate of decay of a fluorescent species from the excited state, which strongly depends on various environmental factors. We observed that the lifetime was high when cross-bridges were bound to actin and low when they were dissociated from it. The lifetime was measured every 50 ms from the center half of the I-band during 60 s of rigor, relaxation and contraction of muscle. We found no differences between lifetimes of Tg-WT and Tg-D166V muscle during rigor, relaxation and contraction. The duty ratio expressed as a fraction of time that cross-bridges spend attached to the thin filaments during isometric contraction was similar in Tg-WT and Tg-D166V muscles. Since independent measurements showed a large decrease in the cross-bridge turnover rate in Tg-D166V muscle compared to Tg-WT, the fact that the duty cycle remains constant suggests that the D166V mutation of RLC causes a decrease in the rate of cross-bridge attachment to actin.

Original languageEnglish
Pages (from-to)1264-1271
Number of pages8
Issue number6
StatePublished - 17 Feb 2009


Dive into the research topics of 'Fluorescence lifetime of actin in the familial hypertrophic cardiomyopathy transgenic heart'. Together they form a unique fingerprint.

Cite this